Is iron therapy for anemia harmful in the setting of infection?

Cleveland Clinic Journal of Medicine

Volumn 78, Issue 3, 2011, Pages 168-170

  Daoud, Ehab ^a   Nakhla, Engi ^b   Sharma, Reecha ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAMPA GENERAL HOSPITAL   (United States)

^c CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ANEMIA; ARTICLE; BACTERIAL INFECTION; HUMAN; RISK;

ANEMIA; BACTERIAL INFECTIONS; HUMANS; IRON; RISK;

EID: 79952226332     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78a.10156     Document Type: Note

References (29)

1. Pieracci FM, Barie PS. Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006; 34:1898-1905.
2. Krantz SB. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci 1994; 307:353-359.
3. Price EA, Schrier SL. Unexplained aspects of anemia of inflammation. Review article. Adv Hematol 2010; 2010:508739.
4. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001; 16:36-41.
5. Wong P, Intragumtornchai T. Hospital-acquired anemia. J Med Assoc Thai [2006;] 89:63-67.
6. Thavendiranathan P, Bagai A, Ebidia A, Detsky AS, Choudhry NK. Do blood tests cause anemia in hospitalized patients? The effect of diagnostic phlebotomy on hemoglobin and hematocrit levels. J Gen Intern Med 2005; 20:520-524.
7. Reade MC, Weissfeld L, Angus DC, Kellum JA, Milbrandt EB. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia. BMC Pulm Med 2010; 10:15.
8. Debellis RJ. Anemia in critical care patients: incidence, etiology, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm 2007; 64:S14-S21.
9. Marik PE. The hazards of blood transfusion. Br J Hosp Med (Lond) 2009; 70:12-15.
10. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007; 357:965-976.
11. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28:2773-2778.
12. Muñoz M, Breymann C, García-Erce JA, Gómez-Ramirez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008; 94:172-183.
13. Pieracci FM, Henderson P, Rodney JR, et al. Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect 2009; 10:9-19.
14. Pieracci FM, Barie PS. Iron and the risk of infection. Surg Infect 2005; 6(suppl 1):S41-S46.
15. Maynor L, Brophy DF. Risk of infections with intravenous iron therapy. Ann Pharmacother 2007; 41:1476-1480.
16. Cavill I. Intravenous iron as adjuvant therapy: a two-edged sword? Nephrol Dial Transplant 2003; 18(suppl 8):viii24- viii28.
17. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993; 64:95-100.
18. Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey. Nephrol Dial Transplant 1995; 10:377-381.
19. Cieri E. Does iron cause bacterial infections in patients with end stage renal disease? ANNA J 1999; 26:591-596.
20. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997; 25:888-895.
21. Brewster UC, Coca SG, Reilly RF, Perazella MA. Effect of intravenous iron on hemodialysis catheter microbial colonization and blood-borne infection. Nephrology 2005; 10:124-128.
22. Aronoff GR, Bennett WM, Blumenthal S, et al. United States Iron Sucrose (Venofer) Clinical Trials Group. Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. Kidney Int 2004; 66:1193-1198.
23. Canziani ME, Yumiya ST, Rangel EB, Manfredi SR, Neto MC, Draibe SA. Risk of bacterial infection in patients under intravenous iron therapy: dose versus length of treatment. Artif Organs 2001; 25:866-869.
24. Collins A, Ma J, Xia H, et al. I.V. iron dosing patterns and hospitalization. J Am Soc Nephrol 1998; 9:204A.
25. Burns DL, Mascioli EA, Bistrian BR. Effect of iron-supplemented total parenteral nutrition in patients with iron deficiency anemia. Nutrition 1996; 12:411-415.
26. Olijhoek G, Megens JG, Musto P, et al. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion [2001;] 41:957-963.
27. Feldman HI, Joffe M, Robinson B, et al. Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 2004; 15:1623-1632.
28. Javadi P, Buchman TG, Stromberg PE, et al. High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit Care Med 2004; 32:1178-1185.
29. Lapointe M. Iron supplementation in the intensive care unit: when, how much, and by what route? Crit Care 2004; 8(suppl 2):S37-S41.